x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- diet and dietary lipidsRemove diet and dietary lipids filter
- phospholipidsRemove phospholipids filter
JLR Patient-Oriented and Epidemiological Research
2 Results
- Patient-Oriented and Epidemiological ResearchOpen Access
Effect of fish oil on monoepoxides derived from fatty acids during cardiac surgery
Journal of Lipid ResearchVol. 57Issue 3p492–498Published online: January 9, 2016- Emmanuel Akintoye
- JasonH.Y. Wu
- Tao Hou
- Xiaoling Song
- Jun Yang
- Bruce Hammock
- and others
Cited in Scopus: 6Our objective was to assess the dynamics of monoepoxides derived from polyunsaturated fatty acids (MEFAs), and their response to n-3 PUFA supplementation, in the setting of acute tissue injury and inflammation (cardiac surgery) in humans. Patients (479) undergoing cardiac surgery in three countries were randomized to perioperative fish oil (EPA + DHA; 8–10 g over 2–5 days preoperatively, then 2 g/day postoperatively) or placebo (olive oil). Plasma MEFAs derived from n-3 and n-6 PUFAs were measured 2 days postoperatively. - Patient-Oriented and Epidemiological ResearchOpen Access
Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk
Journal of Lipid ResearchVol. 56Issue 5p1043–1056Published online: March 15, 2015- Teresa Padro
- Gemma Vilahur
- Joan Sánchez-Hernández
- Marta Hernández
- Rosa M. Antonijoan
- Antonio Perez
- and others
Cited in Scopus: 21The benefits of dietary phytosterols (PhySs) and long-chain n-3 PUFA (ω3) have been linked to their effects as cholesterol- and triglyceride (TGL)-lowering agents. However, it remains unknown whether these compounds have further metabolic effects on LDL lipid composition. Here, we studied the effects of PhyS- or ω3-supplemented low-fat milk (milk) on the LDL-lipidome. Overweight and moderately hypercholesterolemic subjects (n = 32) were enrolled in a two-arm longitudinal crossover study. Milk (250 ml/day), enriched with either 1.57 g PhyS or 375 mg ω3 (EPA + DHA), was given to the participants during two sequential 28 day intervention periods.